Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seyedeh A Najibi

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Performance of Imidazoquinoline Glycoconjugate BAIT628 as a TLR7 Agonist Prodrug for Prostate CancerSeyedeh A Najibi, S M Al Muied Pranto, Muhammad Haroon, et al.
ACS Omega|April 7, 2025
Efflux-Enhanced Imidazoquinolines To Exploit ChemoresistanceMuhammad Haroon, Sharmin Sultana, Seyedeh A Najibi, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Performance of Imidazoquinoline Glycoconjugate BAIT628 as a TLR7 Agonist Prodrug for Prostate CancerSeyedeh A Najibi, S M Al Muied Pranto, Muhammad Haroon, et al.
ACS Omega|April 7, 2025
Efflux-Enhanced Imidazoquinolines To Exploit ChemoresistanceMuhammad Haroon, Sharmin Sultana, Seyedeh A Najibi, et al.
Pageof 1